|
AGPAT5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.656400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.707400E-01 |
| Normal-vs-Stage2 |
6.732800E-01 |
| Normal-vs-Stage3 |
1.081990E-01 |
| Normal-vs-Stage4 |
8.761200E-01 |
| Stage1-vs-Stage2 |
9.708000E-01 |
| Stage1-vs-Stage3 |
6.689500E-02 |
| Stage1-vs-Stage4 |
6.762800E-01 |
| Stage2-vs-Stage3 |
1.044420E-01 |
| Stage2-vs-Stage4 |
6.962200E-01 |
| Stage3-vs-Stage4 |
4.067200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.703200E-01 |
| Normal-vs-AfricanAmerican |
8.545400E-01 |
| Normal-vs-Asian |
1.121510E-03 |
| Caucasian-vs-AfricanAmerican |
6.652600E-01 |
| Caucasian-vs-Asian |
1.525640E-01 |
| AfricanAmerican-vs-Asian |
1.675830E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.838200E-01 |
| Normal-vs-Female |
6.763600E-01 |
| Male-vs-Female |
7.356800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.479800E-01 |
| Normal-vs-Extreme_Weight |
4.412400E-01 |
| Normal-vs-Obese |
4.310400E-01 |
| Normal-vs-Extreme_Obese |
2.710400E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.654000E-01 |
| Normal_Weight-vs-Obese |
8.213600E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.636200E-01 |
| Extreme_Weight-vs-Obese |
2.040200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.698400E-01 |
| Obese-vs-Extreme_Obese |
2.394200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.359800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.072990E-01 |
| Normal-vs-Age(61-80Yrs) |
9.113700E-02 |
| Normal-vs-Age(81-100Yrs) |
2.177600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.952600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.443430E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.178840E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.384700E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.355230E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.839200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.174600E-01 |
| Normal-VS-Type2 PRCC |
4.602200E-01 |
| Normal-VS-KIRP CIMP |
4.873200E-01 |
| Normal-VS-Unclassified PRCC |
1.692810E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.585620E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.994800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.064500E-02 |
| Type2 PRCC-VS-KIRP CIMP |
7.772200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.438600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.731000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.674200E-01 |
| Normal-vs-N1 |
3.307800E-01 |
| Normal-vs-N2 |
8.542400E-01 |
| N0-vs-N1 |
7.461200E-01 |
| N0-vs-N2 |
8.723200E-01 |
| N1-vs-N2 |
7.318800E-01 |
|
|
